NO20033959L - Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon - Google Patents
Benzimidazoler som er nyttige i behandling av seksuell dysfunksjonInfo
- Publication number
- NO20033959L NO20033959L NO20033959A NO20033959A NO20033959L NO 20033959 L NO20033959 L NO 20033959L NO 20033959 A NO20033959 A NO 20033959A NO 20033959 A NO20033959 A NO 20033959A NO 20033959 L NO20033959 L NO 20033959L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- sexual dysfunction
- benzimidazoles useful
- benzimidazoles
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Discharging, Photosensitive Material Shape In Electrophotography (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80353701A | 2001-03-09 | 2001-03-09 | |
| US09/874,484 US20030008878A1 (en) | 2001-03-09 | 2001-06-05 | Benzimidazoles that are useful in treating sexual dysfunction |
| US10/017,939 US20020169166A1 (en) | 2001-03-09 | 2001-12-14 | Benzimidazoles that are useful in treating sexual dysfunction |
| PCT/US2002/007791 WO2002088093A1 (en) | 2001-03-09 | 2002-03-06 | Benzimidazoles that are useful in treating sexual dysfunction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20033959D0 NO20033959D0 (no) | 2003-09-08 |
| NO20033959L true NO20033959L (no) | 2003-11-10 |
| NO326686B1 NO326686B1 (no) | 2009-01-26 |
Family
ID=27360930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033959A NO326686B1 (no) | 2001-03-09 | 2003-09-08 | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20020169166A1 (no) |
| EP (1) | EP1373220B1 (no) |
| JP (1) | JP2005507370A (no) |
| CN (1) | CN100430383C (no) |
| AT (1) | ATE363474T1 (no) |
| AU (1) | AU2002303128B2 (no) |
| BG (1) | BG108230A (no) |
| BR (1) | BR0205812A (no) |
| CA (1) | CA2439943A1 (no) |
| CZ (1) | CZ20032659A3 (no) |
| DE (1) | DE60220385T2 (no) |
| DK (1) | DK1373220T3 (no) |
| ES (1) | ES2287278T3 (no) |
| HK (1) | HK1062174A1 (no) |
| HU (1) | HUP0303413A3 (no) |
| IL (1) | IL157457A0 (no) |
| MX (1) | MXPA03008151A (no) |
| NO (1) | NO326686B1 (no) |
| NZ (1) | NZ527713A (no) |
| PL (1) | PL371272A1 (no) |
| SK (1) | SK12612003A3 (no) |
| UY (1) | UY27203A1 (no) |
| WO (1) | WO2002088093A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022728B2 (en) | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
| US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
| US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| ES2568769T3 (es) | 2003-07-30 | 2016-05-04 | Xenon Pharmaceuticals Inc. | Derivados de piperazina y su uso como agentes terapéuticos |
| AU2004261267B9 (en) * | 2003-07-30 | 2009-04-09 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| AR045496A1 (es) * | 2003-08-29 | 2005-11-02 | Schering Corp | Analolgos de benzimidazolpiperidinas 2- substiyuidas como antagonistas de los receptores de la hormona que concentra melanina selectivos para el tratamiento de la obesidad y trastornos relacionados |
| WO2006034279A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
| TW200626155A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| BRPI0515478A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase |
| TW200626154A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| CN101083982A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 用于治疗硬脂酰CoA去饱和酶介导的疾病的杂环衍生物 |
| CN101084207A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
| BRPI0611187A2 (pt) | 2005-06-03 | 2010-08-24 | Xenon Pharmaceuticals Inc | derivados aminotiazàis como inibidores da estearoil-coa desaturase humana |
| WO2008079945A2 (en) * | 2006-12-20 | 2008-07-03 | University Of South Florida | Rock inhibitors and uses thereof |
| EP2149373A1 (en) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7 receptor ligands and compositions comprising the same |
| EP2545905A1 (en) | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | A new therapeutical composition containing apomorphine as active ingredient |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| FR2665161B1 (fr) * | 1990-07-26 | 1992-11-27 | Esteve Labor Dr | Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments. |
| GB9306578D0 (en) * | 1993-03-30 | 1993-05-26 | Merck Sharp & Dohme | Therapeutic agents |
| DK0882718T3 (da) * | 1995-12-28 | 2005-12-12 | Astellas Pharma Inc | Benzimidazolderivater |
| GB9700878D0 (en) * | 1997-01-17 | 1997-03-05 | Scherer Ltd R P | Dosage forms and method for ameliorating male erectile dysfunction |
| CA2251255A1 (en) * | 1998-10-20 | 2000-04-20 | Mcgill University | The use of dopaminergic agents in the management of sexual dysfunction |
| ES2154605B1 (es) * | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
-
2001
- 2001-12-14 US US10/017,939 patent/US20020169166A1/en not_active Abandoned
-
2002
- 2002-03-06 AU AU2002303128A patent/AU2002303128B2/en not_active Ceased
- 2002-03-06 CA CA002439943A patent/CA2439943A1/en not_active Abandoned
- 2002-03-06 EP EP02731130A patent/EP1373220B1/en not_active Expired - Lifetime
- 2002-03-06 HU HU0303413A patent/HUP0303413A3/hu unknown
- 2002-03-06 CN CNB028093828A patent/CN100430383C/zh not_active Expired - Fee Related
- 2002-03-06 JP JP2002585395A patent/JP2005507370A/ja active Pending
- 2002-03-06 CZ CZ20032659A patent/CZ20032659A3/cs unknown
- 2002-03-06 ES ES02731130T patent/ES2287278T3/es not_active Expired - Lifetime
- 2002-03-06 DK DK02731130T patent/DK1373220T3/da active
- 2002-03-06 AT AT02731130T patent/ATE363474T1/de not_active IP Right Cessation
- 2002-03-06 BR BR0205812-0A patent/BR0205812A/pt not_active IP Right Cessation
- 2002-03-06 PL PL02371272A patent/PL371272A1/xx not_active Application Discontinuation
- 2002-03-06 IL IL15745702A patent/IL157457A0/xx unknown
- 2002-03-06 WO PCT/US2002/007791 patent/WO2002088093A1/en active Application Filing
- 2002-03-06 NZ NZ527713A patent/NZ527713A/en unknown
- 2002-03-06 MX MXPA03008151A patent/MXPA03008151A/es active IP Right Grant
- 2002-03-06 DE DE60220385T patent/DE60220385T2/de not_active Expired - Lifetime
- 2002-03-06 SK SK1261-2003A patent/SK12612003A3/sk not_active Application Discontinuation
- 2002-03-11 UY UY27203A patent/UY27203A1/es not_active Application Discontinuation
-
2003
- 2003-09-08 NO NO20033959A patent/NO326686B1/no not_active IP Right Cessation
- 2003-10-03 BG BG108230A patent/BG108230A/bg unknown
-
2004
- 2004-06-30 HK HK04104714A patent/HK1062174A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1373220B1 (en) | 2007-05-30 |
| NZ527713A (en) | 2006-09-29 |
| HUP0303413A2 (hu) | 2004-01-28 |
| WO2002088093A1 (en) | 2002-11-07 |
| PL371272A1 (en) | 2005-06-13 |
| ES2287278T3 (es) | 2007-12-16 |
| EP1373220A1 (en) | 2004-01-02 |
| UY27203A1 (es) | 2002-10-31 |
| AU2002303128B2 (en) | 2007-11-29 |
| DE60220385D1 (de) | 2007-07-12 |
| BR0205812A (pt) | 2005-05-03 |
| DE60220385T2 (de) | 2008-04-03 |
| HUP0303413A3 (en) | 2007-08-28 |
| NO20033959D0 (no) | 2003-09-08 |
| CN100430383C (zh) | 2008-11-05 |
| NO326686B1 (no) | 2009-01-26 |
| MXPA03008151A (es) | 2004-03-16 |
| HK1062174A1 (en) | 2004-10-21 |
| US20020169166A1 (en) | 2002-11-14 |
| DK1373220T3 (da) | 2007-10-08 |
| JP2005507370A (ja) | 2005-03-17 |
| BG108230A (bg) | 2005-04-30 |
| ATE363474T1 (de) | 2007-06-15 |
| SK12612003A3 (sk) | 2004-04-06 |
| CA2439943A1 (en) | 2002-11-07 |
| IL157457A0 (en) | 2004-03-28 |
| CZ20032659A3 (cs) | 2004-01-14 |
| CN1516693A (zh) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| TW200505903A (en) | CGRP receptor antagonists | |
| NO20033959D0 (no) | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon | |
| DE602004013563D1 (de) | Rantagonisten | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| ATE466860T1 (de) | Cgrp-rezeptorantagonisten | |
| EA200501333A1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| ATE503755T1 (de) | Cgrp-rezeptorantagonisten | |
| WO2003099266A3 (en) | Acetamides and benzamides that are useful in treating sexual dysfunction | |
| PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
| GB0127903D0 (en) | Improvements relating to organic compounds | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| HK1081194A1 (en) | 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| ECSP024244A (es) | Uso de (z)-2-cyano-3-hydroxy-but-2-enoic acid(4´-trifluoromethylphenyl)-amide para el tratamiento de la esclerosis múltiple | |
| YU21404A (sh) | Supstituisana jedinjenja benzimidazola i njihova primena u lečenju raka | |
| ATE443044T1 (de) | Tace inhibitoren | |
| DE60213802D1 (de) | Cak inhibitoren und deren verwendungen | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| ATE329916T1 (de) | Azaindolylpiperidinderivate als antihistaminika und antiallergika | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| ECSP034752A (es) | Benzimidazoles utiles en el tratamiento de la dinfuncion sexual | |
| MY139582A (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
| UY27820A1 (es) | Acetamidas y benzamidas que son útiles en el tratamiento de disfunciones sexuales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |